Edumed s.r.o.

The trials here

What the 2 trials at this site are about, from their registry records.

Conditions

• Atrial fibrillation1 trial
• Chronic kidney disease1 trial
• Obesity1 trial
• Type 2 diabetes1 trial

Phase

• Phase 32 trials

Status

• Active, not recruiting1 trial
• Completed1 trial

Lead sponsor

• Eli Lilly and Company1 trial
• Janssen Research & Development, LLC1 trial

Running trials

• Active, not recruiting

  A Study of Milvexian Versus Apixaban in Participants With Atrial Fibrillation

  NCT05757869· Phase 3· Janssen Research & Development, LLC· Source

Closed trials

• Completed

  A Study of Daily Oral Orforglipron (LY3502970) Compared With Insulin Glargine in Participants With Type 2 Diabetes and Obesity or Overweight at Increased Cardiovascular Risk

  NCT05803421· Phase 3· Eli Lilly and Company· Source